Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Should chronic hepatitis B be treated as early as possible?

Hulstaert F, Schwierz C, Nevens F, Thiry N, Gamil M, Colle I, Van de Sande S, Horsmans Y.

Int J Technol Assess Health Care. 2013 Jan;29(1):35-41. doi: 10.1017/S0266462312000736. Epub 2013 Jan 8.

PMID:
23298548
[PubMed - indexed for MEDLINE]
2.

Calculating an intervention's (cost-)effectiveness for the real-world target population: the potential of combining strengths of both RCTs and observational data.

Neyt M, Cleemput I, Thiry N, De Laet C.

Health Policy. 2012 Jul;106(2):207-10. doi: 10.1016/j.healthpol.2012.04.014. Epub 2012 May 16.

PMID:
22608108
[PubMed - indexed for MEDLINE]
3.

Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions.

Cleemput I, Neyt M, Thiry N, De Laet C, Leys M.

Int J Technol Assess Health Care. 2011 Jan;27(1):71-6. doi: 10.1017/S0266462310001194. Epub 2011 Jan 25. Review.

PMID:
21262069
[PubMed - indexed for MEDLINE]
4.

Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditions.

Neyt M, Devriese S, Thiry N, Van den Bruel A.

BMC Pulm Med. 2010 Sep 15;10:47. doi: 10.1186/1471-2466-10-47.

PMID:
20843311
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium.

Cleemput I, Thiry N.

Pharmacoeconomics. 2009;27(5):433; author reply 433-4. doi: 10.2165/00019053-200927050-00008. No abstract available.

PMID:
19586082
[PubMed - indexed for MEDLINE]
6.

Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening.

Thiry N, De Laet C, Hulstaert F, Neyt M, Huybrechts M, Cleemput I.

Int J Technol Assess Health Care. 2009 Apr;25(2):161-70. doi: 10.1017/S0266462309090217.

PMID:
19366497
[PubMed - indexed for MEDLINE]
7.

Cost effectiveness of implantable cardioverter-defibrillators for primary prevention in a Belgian context.

Neyt M, Thiry N, Ramaekers D, Van Brabandt H.

Appl Health Econ Health Policy. 2008;6(1):67-80.

PMID:
18774871
[PubMed - indexed for MEDLINE]
8.

Introduction of emerging medical devices on the market: a new procedure in Belgium.

Vinck I, Neyt M, Thiry N, Louagie M, Ramaekers D.

Int J Technol Assess Health Care. 2007 Fall;23(4):449-54.

PMID:
17937833
[PubMed - indexed for MEDLINE]
9.

Varicella vaccination in Europe: are we ready for a universal childhood programme?

Sengupta N, Booy R, Schmitt HJ, Peltola H, Van-Damme P, Schumacher RF, Campins M, Rodrigo C, Heikkinen T, Seward J, Jumaan A, Finn A, Olcén P, Thiry N, Weil-Olivier C, Breuer J.

Eur J Pediatr. 2008 Jan;167(1):47-55. Epub 2007 Mar 3.

PMID:
17334784
[PubMed - indexed for MEDLINE]
10.

Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006).

Beutels P, Thiry N, Van Damme P.

Vaccine. 2007 Feb 9;25(8):1355-67. Epub 2006 Nov 3. Review.

PMID:
17208339
[PubMed - indexed for MEDLINE]
11.

Economic evaluations of pneumococcal vaccination strategies in adults. A summary of the results.

Thiry N, Beutels P, Van Damme P.

Acta Clin Belg. 2005 Nov-Dec;60(6):338-44. Review.

PMID:
16502594
[PubMed - indexed for MEDLINE]
12.

Recommendations for the use of the 23-valent polysaccharide pneumococcal vaccine in adults: a Belgian consensus report.

Peetermans WE, Van de Vyver N, Van Laethem Y, Van Damme P, Thiry N, Trefois P, Geerts P, Schetgen M, Peleman R, Swennen B, Verhaegen J.

Acta Clin Belg. 2005 Nov-Dec;60(6):329-37. Review.

PMID:
16502593
[PubMed - indexed for MEDLINE]
13.

[Varicella-zoster virus seroprevalence in nursery and day-care workers in Lyon (France)].

Reignier F, Romanò L, Thiry N, Beutels P, Van Damme P, Fau C, Gaspard C, Mamoux V, Zanetti A, Floret D.

Med Mal Infect. 2005 Apr;35(4):192-6. French.

PMID:
15914287
[PubMed - indexed for MEDLINE]
14.

An economic evaluation of varicella vaccination in Italian adolescents.

Thiry N, Beutels P, Tancredi F, Romanò L, Zanetti A, Bonanni P, Gabutti G, Van Damme P.

Vaccine. 2004 Sep 9;22(27-28):3546-62.

PMID:
15315834
[PubMed - indexed for MEDLINE]
15.

Economic evaluations of varicella vaccination programmes: a review of the literature.

Thiry N, Beutels P, Van Damme P, Van Doorslaer E.

Pharmacoeconomics. 2003;21(1):13-38. Review.

PMID:
12484801
[PubMed - indexed for MEDLINE]
16.

The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium).

Thiry N, Beutels P, Shkedy Z, Vranckx R, Vandermeulen C, Wielen MV, Damme PV.

Eur J Pediatr. 2002 Nov;161(11):588-93. Epub 2002 Sep 24.

PMID:
12424583
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk